The effectiveness of therapy on outcome following (BoNT-A) injection for focal spasticity in adults with neurological conditions: A systematic review

References

• Olver J, Esquenazi A, Fung VSC, Singer BJ, Ward AB. Botulinum toxin assessment, intervention and aftercare for lower limb disorders of movement and muscle tone in adults: International consensus statement. European Journal of Neurology 2010;17:57–73
   PubMed Web of Science ®Google Scholar
• Esquenazi A, Novak I, Sheean G, Singer BJ, Ward AB. International consensus statement for the use of botulinum toxin treatment in adults and children with neurological impairments - Introduction. European Journal of Neurology 2010;17:1–8
   PubMed Web of Science ®Google Scholar
• Sheean G, Lannin NA, Turner-Stokes L, Rawicki B, Snow BJ. Botulinum toxin assessment, intervention and after-care for upper limb hypertonicity in adults: International consensus statement. European Journal of Neurology 2010;17:74–93
   PubMed Web of Science ®Google Scholar
• Verplancke D, Snape S, Salisbury CF, Jones PW, Ward AB. A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clinical Rehabilitation 2005;19:117–125
   PubMed Web of Science ®Google Scholar
• Farina S, Migliorini C, Gandolfi M, Bertolasi L, Casarotto M, Manganotti P, Fiaschi A, Smania N. Combined effects of botulinum toxin and casting treatments on lower limb spasticity after stroke. Functional Neurology 2008;23:87–91
   PubMed Web of Science ®Google Scholar
• Lai JM, Francisco GE, Willis FB. Dynamic splinting after treatment with botulinum toxin type-A: A randomized controlled pilot study. Advances in Therapy 2009;26:241–248
   PubMed Web of Science ®Google Scholar
• Weber DJ, Skidmore ER, Niyonkuru C, Chang C-L, Huber LM, Munin MC. Cyclic functional electrical stimulation does not enhance gains in hand grasp function when used as an adjunct to onabotulinumtoxina and task practice therapy: A single-blind, randomized controlled pilot study. Archives of Physical Medicine & Rehabilitation 2010;91:679–686
   PubMed Web of Science ®Google Scholar
• Sun S, Hsu C, Sun H, Hwang C, Yang C, Wang J. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: A randomized controlled study. Neurorehabilitation & Neural Repair 2010;24:34–41
   PubMed Web of Science ®Google Scholar
• Williams G, Olver J, de Graaff S, Singer BJ. The use of botulinum toxin type A in the management of adult-onset focal spasticity: A survey of Australian allied health professionals. Australian Occupational Therapy Journal 2012;59:257–264
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, Coxon L. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 2001;559–565
   PubMed Web of Science ®Google Scholar
• Pandyan AD, Vuadens P, van Wijck FMJ, Stark S, Johnson GR, Barnes MP. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox[sup ®] to the elbow flexors in a unilateral stroke population. Clinical Rehabilitation 2002;16:654–660
   PubMed Web of Science ®Google Scholar
• Bakheit AM, Thilmann AF, Ward AB, Poewe W, Wissel J, Muller J, Benecke R, Collin C, Muller F, Ward CD, Neumann C. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke; a Journal of Cerebral Circulation 2000;31:2402–2406
   PubMed Web of Science ®Google Scholar
• Simpson DM, Alexander DN, O'Brien CF, Tagliati M, Aswad AS, Leon JM, Gibson J, Mordaunt JM, Monaghan EP. Botulinum toxin type A in the treatment of upper extremity spasticity: A randomized, double-blind, placebo-controlled trial. Neurology 1996;46:1306–1310
   PubMed Web of Science ®Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Annals of Internal Medicine. 2009;151:264–269
   Google Scholar
• Verhagen AP, de Vet HCW, de Bie RA, Kessels AGH, Boers M, Bouter LM, Knipschild PG. The Delphi List: A criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi Consensus. Journal of Clinical Epidemiology 1998;51:1235–1241
   PubMed Web of Science ®Google Scholar
• Haidich A. Meta-analysis in medical research. Hippokratia 2010;14(Suppl 1):29
   Web of Science ®Google Scholar
• AAN (American Academy of Neurology). Clinical Practice Guideline Process Manual, 2011 ed. St. Paul, MN: The American Academy of Neurology; 2011
   Google Scholar
• Carda S, Invernizzi M, Baricich A, Cisari C. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: A single-blind randomized trial on adult stroke patients. Clinical Rehabilitation 2011;25:1119–1127
   PubMed Web of Science ®Google Scholar
• Baricich A, Carda S, Bertoni M, Maderna L, Cisari C. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. Journal of Rehabilitation Medicine 2008;40:870–872
   PubMed Web of Science ®Google Scholar
• Paoloni M, Giovannelli M, Mangone M, Leonardi L, Tavernese E, Di Pangrazio E, Bernetti A, Santilli V, Pozzilli C. Does giving segmental muscle vibration alter the response to botulinum toxin injections in the treatment of spasticity in people with multiple sclerosis? A single-blind randomized controlled trial. Clinical Rehabilitation 2013;27:803–812
   PubMed Web of Science ®Google Scholar
• Bayram S, Sivrioglu K, Karli N, Ozcan O. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: A preliminary study. American Journal of Physical Medicine & Rehabilitation 2006;85:75–81
   PubMed Web of Science ®Google Scholar
• Hesse S, Jahnke MT, Luecke D, Mauritz KH. Short-term electrical stimulation enhances the effectiveness of Botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neuroscience Letters 1995;201:37–40
   PubMed Web of Science ®Google Scholar
• Karadag-Saygi E, Cubukcu-Aydoseli K, Kablan N, Ofluoglu D. The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Topics in Stroke Rehabilitation 2010;17:318–322
   PubMed Web of Science ®Google Scholar
• Reiter F, Danni M, Lagalla G, Ceravolo G, Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Archives of Physical Medicine & Rehabilitation 1998;79:532–535
   PubMed Web of Science ®Google Scholar
• Hesse S, Reiter F, Konrad M, Jahnke MT. Botulinum toxin type A and short-term electrical stimulation in the treatment of upper limb flexor spasticity after stroke: A randomized, double-blind, placebo-controlled trial. Clinical Rehabilitation 1998;12:381–388
   PubMed Web of Science ®Google Scholar
• Maher CG, Sherrington C, Herbert RD, Moseley AM, Elkins M. Reliability of the PEDro scale for rating quality of randomized controlled trials. Physical Therapy 2003;83:713–721
   PubMed Web of Science ®Google Scholar
• Francis HP, Wade DT, Turner-Stokes L, Kingswell RS, Dott CS, Coxon EA. Does reducing spasticity translate into functional benefit? An exploratory meta-analysis. Journal of Neurology, Neurosurgery & Psychiatry 2004;75:1547–1551
   PubMed Web of Science ®Google Scholar
• van der Putten JJMF, Hobart JC, Freeman JA, Thompson AJ. Measuring change in disability after inpatient rehabilitation: Comparison of the responsiveness of the Barthel Index and the Functional Independence Measure. Journal of Neurology, Neurosurgery & Psychiatry 1999;66:480–484
   PubMed Web of Science ®Google Scholar
• Ashford S, Turner-Stokes L. Goal attainment for spasticity management using botulinum toxin. Physiotherapy Research International 2006;11:24–34
   PubMedGoogle Scholar